OBJECTIVE: Scleroderma is a genetically complex autoimmune disease with substantial phenotypic heterogeneity. Previous genome-wide association studies have identified common genetic variants associated with disease risk, but these studies are not designed to capture rare or potential causal variants. Our goal was to identify rare as well as common genetic variants in patients with diffuse cutaneous systemic sclerosis (dcSSc) through whole-exome sequencing (WES) in order to identify potential causal variants. METHODS: We generated WES data for 32 dcSSc patients with or without interstitial lung disease (ILD) and for 17 healthy "in-house" controls. Variants were annotated and filtered by quality, minor allele frequency, and deleterious effects on gene function. We applied a gene burden test to identify novel dcSSc and dcSSc-associated ILD candidate genes that were enriched with deleterious variants in cases compared to in-house controls as well as controls from the 1000 Genomes Project (n = 130). RESULTS: We identified 70 genes that were enriched with deleterious variants in dcSSc patients. Two of them (BANK1 and TERT) were in pathways previously implicated in SSc or ILD pathogenesis or known susceptibility loci. Newly identified genes (COL4A3, COL4A4, COL5A2, COL13A1, and COL22A1) were significantly enriched in the extracellular matrix-related pathway, which is relevant to the fibrotic features of dcSSc, and in the DNA repair pathway (XRCC4). CONCLUSION: This study demonstrates the value of WES for the identification of novel gene variants and pathways that may contribute to scleroderma risk and/or severity. The candidate genes we discovered are potential targets for in-depth functional studies.
OBJECTIVE:Scleroderma is a genetically complex autoimmune disease with substantial phenotypic heterogeneity. Previous genome-wide association studies have identified common genetic variants associated with disease risk, but these studies are not designed to capture rare or potential causal variants. Our goal was to identify rare as well as common genetic variants in patients with diffuse cutaneous systemic sclerosis (dcSSc) through whole-exome sequencing (WES) in order to identify potential causal variants. METHODS: We generated WES data for 32 dcSSc patients with or without interstitial lung disease (ILD) and for 17 healthy "in-house" controls. Variants were annotated and filtered by quality, minor allele frequency, and deleterious effects on gene function. We applied a gene burden test to identify novel dcSSc and dcSSc-associated ILD candidate genes that were enriched with deleterious variants in cases compared to in-house controls as well as controls from the 1000 Genomes Project (n = 130). RESULTS: We identified 70 genes that were enriched with deleterious variants in dcSSc patients. Two of them (BANK1 and TERT) were in pathways previously implicated in SSc or ILD pathogenesis or known susceptibility loci. Newly identified genes (COL4A3, COL4A4, COL5A2, COL13A1, and COL22A1) were significantly enriched in the extracellular matrix-related pathway, which is relevant to the fibrotic features of dcSSc, and in the DNA repair pathway (XRCC4). CONCLUSION: This study demonstrates the value of WES for the identification of novel gene variants and pathways that may contribute to scleroderma risk and/or severity. The candidate genes we discovered are potential targets for in-depth functional studies.
Authors: Li Gao; Mary J Emond; Tin Louie; Chris Cheadle; Alan E Berger; Nicholas Rafaels; Candelaria Vergara; Yoonhee Kim; Margaret A Taub; Ingo Ruczinski; Stephen C Mathai; Stephen S Rich; Deborah A Nickerson; Laura K Hummers; Michael J Bamshad; Paul M Hassoun; Rasika A Mathias; Kathleen C Barnes Journal: Arthritis Rheumatol Date: 2016-01 Impact factor: 10.995
Authors: E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim Journal: J Rheumatol Date: 1988-02 Impact factor: 4.666
Authors: Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope Journal: Arthritis Rheum Date: 2013-10-03
Authors: P Dieudé; J Wipff; M Guedj; B Ruiz; I Melchers; E Hachulla; G Riemekasten; E Diot; N Hunzelmann; J Sibilia; K Tiev; L Mouthon; J L Cracowski; P H Carpentier; J Distler; Z Amoura; I Tarner; J Avouac; O Meyer; A Kahan; C Boileau; Y Allanore Journal: Arthritis Rheum Date: 2009-11
Authors: Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann Journal: Am J Respir Crit Care Med Date: 2011-03-15 Impact factor: 21.405
Authors: Matthew R Nelson; Daniel Wegmann; Margaret G Ehm; Darren Kessner; Pamela St Jean; Claudio Verzilli; Judong Shen; Zhengzheng Tang; Silviu-Alin Bacanu; Dana Fraser; Liling Warren; Jennifer Aponte; Matthew Zawistowski; Xiao Liu; Hao Zhang; Yong Zhang; Jun Li; Yun Li; Li Li; Peter Woollard; Simon Topp; Matthew D Hall; Keith Nangle; Jun Wang; Gonçalo Abecasis; Lon R Cardon; Sebastian Zöllner; John C Whittaker; Stephanie L Chissoe; John Novembre; Vincent Mooser Journal: Science Date: 2012-05-17 Impact factor: 47.728
Authors: B Rueda; P Gourh; J Broen; S K Agarwal; C Simeon; N Ortego-Centeno; M C Vonk; M Coenen; G Riemekasten; N Hunzelmann; R Hesselstrand; F K Tan; J D Reveille; S Assassi; F J Garcia-Hernandez; P Carreira; M Camps; A Fernandez-Nebro; P Garcia de la Peña; T Nearney; D Hilda; M A Gónzalez-Gay; P Airo; L Beretta; R Scorza; T R D J Radstake; M D Mayes; F C Arnett; J Martin Journal: Ann Rheum Dis Date: 2009-10-08 Impact factor: 19.103
Authors: Erica L Herzog; Aditi Mathur; Andrew M Tager; Carol Feghali-Bostwick; Frank Schneider; John Varga Journal: Arthritis Rheumatol Date: 2014-08 Impact factor: 10.995
Authors: Maureen D Mayes; James V Lacey; Jennifer Beebe-Dimmer; Brenda W Gillespie; Brenda Cooper; Timothy J Laing; David Schottenfeld Journal: Arthritis Rheum Date: 2003-08
Authors: Pravitt Gourh; Elaine F Remmers; Steven E Boyden; Theresa Alexander; Nadia D Morgan; Ami A Shah; Maureen D Mayes; Ayo Doumatey; Amy R Bentley; Daniel Shriner; Robyn T Domsic; Thomas A Medsger; Virginia D Steen; Paula S Ramos; Richard M Silver; Benjamin Korman; John Varga; Elena Schiopu; Dinesh Khanna; Vivien Hsu; Jessica K Gordon; Lesley Ann Saketkoo; Heather Gladue; Brynn Kron; Lindsey A Criswell; Chris T Derk; S Louis Bridges; Victoria K Shanmugam; Kathleen D Kolstad; Lorinda Chung; Reem Jan; Elana J Bernstein; Avram Goldberg; Marcin Trojanowski; Suzanne Kafaja; Kathleen M Maksimowicz-McKinnon; James C Mullikin; Adebowale Adeyemo; Charles Rotimi; Francesco Boin; Daniel L Kastner; Fredrick M Wigley Journal: Arthritis Rheumatol Date: 2018-08-29 Impact factor: 10.995
Authors: Aida Moreno-Moral; Marta Bagnati; Surya Koturan; Jeong-Hun Ko; Carmen Fonseca; Nathan Harmston; Laurence Game; Javier Martin; Voon Ong; David J Abraham; Christopher P Denton; Jacques Behmoaras; Enrico Petretto Journal: Ann Rheum Dis Date: 2018-01-17 Impact factor: 19.103